Source: Investing.com ↗

Roivant reports positive phase 2 trial results for mosliciguat

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.02%

BTC/USDT

$85,681.72

-0.24%

ETH/USDT

$2,728.47

-0.46%

ZEC/USDT

$1,607.82

+6.92%

XRP/USDT

$1.58

+3.58%